0A8M fundamentals
An in-depth look to AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) operating, investing, and financing activities
0A8M free cash flow for Q2 24 is -135 k USD. For 2023, 0A8M free cash flow was -5.22 M USD and operating cash flow was -5.22 M USD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM